Are we chasing longevity all wrong? Top doctor's candid post urges shift from biohacking, anti-aging obsession
Why healthspan matters more than ever
In a world obsessed with living longer, are we overlooking what really matters—living well? In a powerful and emotionally charged Instagram post, Dr. Sanjay Bhojraj, a leading US-based interventional cardiologist and founder of the Well12 wellness program, challenged the very foundation of the modern longevity movement. His message? A longer life doesn't mean a better one.'Longevity is everywhere… but we're not living better,' reads the text of his viral post. Surrounded by trends like cold plunges, anti-aging supplements, and flashy biohacks , many today are chasing added years with little thought to what those years actually look like. Dr. Bhojraj argues that while medical advancements may have stretched the average lifespan, they've done little to prevent a painful truth: Americans now spend over 12 years in poor health toward the end of their lives.'That's more than a decade of daily meds, low energy, pain, and cognitive decline,' he wrote in his caption, adding that we've succeeded in extending life—but at the cost of vitality and dignity. The sobering reality, he notes, is that we're 'just living longer… while sicker.' His post strikes at the heart of the longevity narrative, exposing a hard truth often hidden beneath headlines and health fads.Dr. Bhojraj's solution isn't found in another supplement or a viral health hack—it's in reframing the conversation. 'Living longer doesn't necessarily mean living better,' he stated. 'It's time to shift the conversation from merely adding years to ensuring those years are vibrant and fulfilling.' This, he explains, is the distinction between lifespan and healthspan—a term increasingly used by health professionals to emphasize not just how long one lives, but how well.The cardiologist, known for combining evidence-based medicine with holistic wellness, has long advocated for addressing the root causes of disease . His integrative approach blends nutrition, genomics, breathwork, sleep, and stress management—an ecosystem of habits meant to extend vitality, not just life.He urges patients and practitioners to focus less on living forever and more on feeling alive. 'Let's redefine what it means to age well,' his post concludes—a sentiment that resonates deeply in a time where longevity often overshadows quality.Dr. Bhojraj's post is more than a medical observation; it's a cultural critique. It reminds us that the true goal of health isn't merely to survive more birthdays—but to live each year with energy, clarity, and purpose. In the race for longer lives, he challenges us to pause and ask: what are we really running toward?
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
38 minutes ago
- Time of India
Cipla eyes entry into India's weight management market amid rising demand and global competition
Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has said. The Mumbai-based firm is also strengthening its presence in the central nervous system (CNS) therapeutic area, he stated in his address to shareholders in the company's Annual Report for 2024-25. "Our efforts are rooted in understanding patient needs, reducing stigma, and delivering differentiated therapies for niche is emerging as a priority area for Cipla. With a clear strategic intent, we are preparing to enter the weight management segment in India, aiming to address the rising demand for effective obesity solutions," Vohra stated. Several domestic drug firms are developing drugs for weight loss to capitalise on the growing market for obesity and diabetes management. US drugmaker Eli Lilly & Co has already launched its anti-obesity drug Mounjaro in the country. Live Events Danish firm Novo Nordisk has also launched its anti-obesity drug Wegovy, indicated for both long-term chronic weight management and reduction in risk of major adverse cardiovascular events. In the CNS segment, Cipla has successfully in-licensed Sanofi's India CNS product range, including Frisium, a leading brand in the anti-epileptic category, Vohra informed shareholders. "Building on this momentum, we aim to pursue similar in-licensing deals or acquisitions in niche indications of attention deficit hyperactivity disorder (ADHD) and Parkinson's disease," he said. The company is equally committed to addressing the global crisis of antimicrobial resistance (AMR), he added. "Our AMR portfolio is evolving from volume-based to innovation-led, with four novel products in development," Vohra said. He noted that the company's ambition is to be a global, innovation-led, patient-centric healthcare company that creates long-term value through science, empathy, and sustainability. "We will continue to invest in big brands, strategic alliances, digital infrastructure, and next-generation therapies, while remaining rooted in our founding values of care and compassion," Vohra stated. Cipla's consolidated revenue stood at Rs 27,548 crore in FY25. Its consolidated net profit rose to Rs 5,272 crore during the period.
Time of India
an hour ago
- Time of India
Fentanyl crisis takes center stage in US-China trade negotiations: Here's why
Trade policy as a weapon against Fentanyl China's response and diplomatic tensions Live Events Fentanyl's role in trade talks The stakes US Customs and Border Protection (CBP) reports that seizures of fentanyl at the border have doubled in the past two years, yet the supply remains robust, fueling the urgency behind the US's hardline stance. The ongoing dispute threatens to disrupt global supply chains, with the fentanyl crisis now influencing tariffs on a wide range of goods, from electronics to pharmaceuticals. The August 14 window is critical: if no further agreement is reached, tariffs could snap back to higher levels, with the fentanyl tariff remaining a central point of contention. (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel The ongoing US-China trade talks have placed fentanyl—a deadly synthetic opioid—at the heart of economic diplomacy, underscoring how a public health emergency has become a central bargaining chip in global commerce. The Trump administration has repeatedly accused China of enabling the flow of fentanyl and its chemical precursors into the United States, leading to a surge in overdose deaths and prompting unprecedented tariffs that have reshaped the trade is a synthetic opioid up to 50 times stronger than heroin and 100 times more potent than morphine. Just 2 milligrams—an amount smaller than a few grains of sand—can cause a fatal overdose. The US has faced a relentless wave of fentanyl-related deaths, with tens of thousands of Americans dying annually from overdoses linked to the drug and its analogues. The Centers for Disease Control and Prevention (CDC) estimates that synthetic opioids , primarily fentanyl, are responsible for over 70,000 overdose deaths in the US each response to the crisis, President Trump stated an emergency and imposed a 20% "fentanyl tariff" on all Chinese imports, explicitly linking trade penalties to China's alleged failure to stem the flow of fentanyl precursors to Mexican drug cartels , which then traffic the drug into the US. This fentanyl tariff remains in place even as broader tariffs have been temporarily reduced following recent trade negotiations.'The flow of contraband drugs like fentanyl to the United States, through illicit distribution networks, has created a national emergency, including a public health crisis. Chinese officials have failed to take the actions necessary to stem the flow of precursor chemicals to known criminal cartels,' stated the White has pushed back, arguing that the US opioid crisis is rooted in domestic misuse and regulatory failures, not Chinese exports. Still, in a move seen as a gesture of goodwill, China recently tightened controls on two key chemicals used in fentanyl production, adding them to a list of strictly regulated 4-ANPP and NPP are widely recognized as the most immediate precursors used in illicit fentanyl synthesis. Chinese authorities have also added other related substances to their control lists in line with United Nations recommendations, and are working to schedule additional chemicals such as 4-piperidone and officials, however, maintain that the ultimate responsibility lies with the US:'Fentanyl is the U.S.'s problem, not China's. The responsibility to resolve this issue lies with the United States,' said Guo Jiakun, spokesperson for China's Foreign 20% fentanyl tariff is now a sticking point in ongoing negotiations. While both countries have agreed to temporarily lower other tariffs, the fentanyl-related duties remain, reflecting the issue's political and public health gravity. The US insists that further progress on trade depends on China's willingness to clamp down on fentanyl precursors, while China views the tariff as punitive and based on a mischaracterization of the crisis.
NDTV
2 hours ago
- NDTV
Love Palak Patta Chaat? Now Enjoy It Guilt-Free With This No-Oil Recipe
Palak patta chaat is one of the most loved varieties of chaat out there. Crispy palak leaves topped with yoghurt and tangy chutneys offer a burst of flavours in your mouth. But the problem is that making it requires deep-frying the palak leaves, which can quickly add up calories. If you're trying to lose weight, this can be a big no-no. But what if we told you that you can enjoy the same flavours of palak patta chaat minus the guilt? Yes, it's possible! Don't worry, it's just as delicious as the regular palak patta chaat. Introducing: No-Oil Palak Patta Chaat. The recipe was shared by the Instagram page @okaysimrann. Intrigued to know how to make it? Read on! Also Read: Enjoy Chaat Minus The Guilt! This High-Protein Rajma Tikki Chaat Deserves Your Attention Is Palak Patta Chaat Healthy? Palak patta chaat can be a healthy option, especially when made with minimal oil and loaded with nutritious toppings like curd, pomegranate and chana. Spinach is rich in antioxidants and iron, making it a great base for a healthy snack. Is Palak Patta Chaat Gluten-Free? Palak patta chaat is 100% gluten-free, making it a great option for those with gluten intolerance or sensitivity. The crispy spinach snack is naturally free from gluten and you can enjoy it without worrying about adverse reactions. Does No-Oil Palak Patta Chaat Taste As Good As Regular Palak Patta Chaat? Yes, no-oil palak patta chaat can taste just as good as the regular version! Using an air fryer helps retain the crispy texture, and the flavours from the spices and chutneys can still shine through. The absence of excess oil doesn't compromise on the flavor, making it a great alternative for a healthier snack. How To Make No-Oil Palak Patta Chaat | Palak Patta Chaat Recipe To make this chaat, you just need a handful of ingredients and 10 minutes of your time. Follow these steps: Wash the palak leaves thoroughly and pat them dry. Now, make a thick slurry with besan, red chilli powder, coriander powder, salt and water. Dip each dry spinach leaf in the batter, ensuring it's well-coated on both sides. Place the leaves in a preheated air fryer and cook at 180 degrees C for about 8-10 minutes or until golden and crispy. Top with curd, chutneys, aloo, chana, pomegranate, cumin and salt. Serve immediately before it gets soggy! Watch the full recipe video below: View this post on Instagram A post shared by Simran Vohra (@okaysimrann) So, why wait? Head to your kitchen and give this no-oil palak patta chaat a try today! Happy Snacking!
